Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) promotes challenging immune and inflammatory phenomena. Though various therapeutic possibilities have been tested against coronavirus disease 2019 (COVID-19), the most adequate treatment has not yet been established. Propolis i...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Biomed Pharmacother
Main Authors: Silveira, Marcelo Augusto Duarte, De Jong, David, Berretta, Andresa Aparecida, Galvão, Erica Batista dos Santos, Ribeiro, Juliana Caldas, Cerqueira-Silva, Thiago, Amorim, Thais Chaves, Conceição, Luis Filipe Miranda Rebelo da, Gomes, Marcel Miranda Dantas, Teixeira, Maurício Brito, Souza, Sergio Pinto de, Santos, Marcele Helena Celestino Alves dos, San Martin, Raissa Lanna Araújo, Silva, Márcio de Oliveira, Lírio, Monique, Moreno, Lis, Sampaio, Julio Cezar Miranda, Mendonça, Renata, Ultchak, Silviana Salles, Amorim, Fabio Santos, Ramos, João Gabriel Rosa, Batista, Paulo Benigno Pena, Guarda, Suzete Nascimento Farias da, Mendes, Ana Verena Almeida, Passos, Rogerio da Hora
Format: Artigo
Jezik:Inglês
Izdano: The Authors. Published by Elsevier Masson SAS. 2021
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7980186/
https://ncbi.nlm.nih.gov/pubmed/34311528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopha.2021.111526
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki